Bromfenac (Broksinak) — a new word in the nonsteroidal antiinflamatory drug (literature review)

Eye inflammation can be caused by different factors — allergies, infection, trauma (including surgery). It can have severe complications, last even after elimination the reason and cause the visual impairment as an outcome. Two main classes of anti-inflammatory agents (corticosteroids and nonsteroid...

Full description

Saved in:
Bibliographic Details
Main Author: E. A. Spiridonov
Format: Article
Language:Russian
Published: Ophthalmology Publishing Group 2016-01-01
Series:Oftalʹmologiâ
Subjects:
Online Access:https://www.ophthalmojournal.com/opht/article/view/272
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839571206096814080
author E. A. Spiridonov
author_facet E. A. Spiridonov
author_sort E. A. Spiridonov
collection DOAJ
description Eye inflammation can be caused by different factors — allergies, infection, trauma (including surgery). It can have severe complications, last even after elimination the reason and cause the visual impairment as an outcome. Two main classes of anti-inflammatory agents (corticosteroids and nonsteroidal anti-inflammatory drugs (NSAIDs)) are used for the prevention and relief of the inflammatory process. Along with the fact that corticosteroids are the «gold standard» treatment of inflammation in ophthalmology, they have a number of serious side effects such as increasing of intraocular pressure and the risk of developing glaucoma, cataracts, activation of bacterial, viral infection and herpes. The positive effects of NSAIDs in comparison with corticosteroids are stable intraocular pressure (IOP), analgesic effect and reduce the risk of secondary infection. The three classes of NSADs are currently used in ophthalmology. They are phenylacetic acid (diclofenac and bromfenac nepafenak), indole acetic acid (indomethacin) and geteroariluksunoy acid (ketorolac). The last synthesized NSAIDs for ophthalmology are amfenac and bromfenac. Bromfenac is effective for the relief of the inflammatory symptoms of and fully complies with the requirements for the ideal anti-inflammatory drugs such as good a penetration ability, creating a sufficient concentration inside the eye, the activity of cyclooxygenase, inhibiting the progress of macular edema, a good analgesic effect, minimal toxicity, comfort of use patients. Bromfenac is the only nonsteroidal antiinflammatory drugs, which is applied once a day and has a pronounced anti-inflammatory action.
format Article
id doaj-art-1b0ecd3fd93949f48419d08f9b1081b9
institution Matheson Library
issn 1816-5095
2500-0845
language Russian
publishDate 2016-01-01
publisher Ophthalmology Publishing Group
record_format Article
series Oftalʹmologiâ
spelling doaj-art-1b0ecd3fd93949f48419d08f9b1081b92025-08-04T14:32:18ZrusOphthalmology Publishing GroupOftalʹmologiâ1816-50952500-08452016-01-01124182610.18008/1816-5095-2015-4-18-26262Bromfenac (Broksinak) — a new word in the nonsteroidal antiinflamatory drug (literature review)E. A. Spiridonov0State Budget Organization of Healthcare «Samara Regional Clinical Ophthalmologic Hospital named T.I. Eroshevsky»Eye inflammation can be caused by different factors — allergies, infection, trauma (including surgery). It can have severe complications, last even after elimination the reason and cause the visual impairment as an outcome. Two main classes of anti-inflammatory agents (corticosteroids and nonsteroidal anti-inflammatory drugs (NSAIDs)) are used for the prevention and relief of the inflammatory process. Along with the fact that corticosteroids are the «gold standard» treatment of inflammation in ophthalmology, they have a number of serious side effects such as increasing of intraocular pressure and the risk of developing glaucoma, cataracts, activation of bacterial, viral infection and herpes. The positive effects of NSAIDs in comparison with corticosteroids are stable intraocular pressure (IOP), analgesic effect and reduce the risk of secondary infection. The three classes of NSADs are currently used in ophthalmology. They are phenylacetic acid (diclofenac and bromfenac nepafenak), indole acetic acid (indomethacin) and geteroariluksunoy acid (ketorolac). The last synthesized NSAIDs for ophthalmology are amfenac and bromfenac. Bromfenac is effective for the relief of the inflammatory symptoms of and fully complies with the requirements for the ideal anti-inflammatory drugs such as good a penetration ability, creating a sufficient concentration inside the eye, the activity of cyclooxygenase, inhibiting the progress of macular edema, a good analgesic effect, minimal toxicity, comfort of use patients. Bromfenac is the only nonsteroidal antiinflammatory drugs, which is applied once a day and has a pronounced anti-inflammatory action.https://www.ophthalmojournal.com/opht/article/view/272eye inflammationcorticosteroidsnon-hormonal anti-inflammatory agentsbromfenac
spellingShingle E. A. Spiridonov
Bromfenac (Broksinak) — a new word in the nonsteroidal antiinflamatory drug (literature review)
Oftalʹmologiâ
eye inflammation
corticosteroids
non-hormonal anti-inflammatory agents
bromfenac
title Bromfenac (Broksinak) — a new word in the nonsteroidal antiinflamatory drug (literature review)
title_full Bromfenac (Broksinak) — a new word in the nonsteroidal antiinflamatory drug (literature review)
title_fullStr Bromfenac (Broksinak) — a new word in the nonsteroidal antiinflamatory drug (literature review)
title_full_unstemmed Bromfenac (Broksinak) — a new word in the nonsteroidal antiinflamatory drug (literature review)
title_short Bromfenac (Broksinak) — a new word in the nonsteroidal antiinflamatory drug (literature review)
title_sort bromfenac broksinak a new word in the nonsteroidal antiinflamatory drug literature review
topic eye inflammation
corticosteroids
non-hormonal anti-inflammatory agents
bromfenac
url https://www.ophthalmojournal.com/opht/article/view/272
work_keys_str_mv AT easpiridonov bromfenacbroksinakanewwordinthenonsteroidalantiinflamatorydrugliteraturereview